Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

Clinical trial NCT00407537 · COMPLETED

Trial details

NCT number: NCT00407537
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Hypercholesterolemia

Start date: 2007-03-01
Primary completion: 2009-10-01
Enrollment: 1531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.